hsCRP

Lund, Sweden, September 7, 2026 SynAct Pharma AB has reported further analyses from its Phase 2b ADVANCE clinical trial...

LAUSANNE, Switzerland, August 20, 2026 AC Immune SA announced positive preliminary Phase 1 clinical data for ACI-19764, its wholly...

BAGSVÆRD, Denmark, July 31, 2026 Novo Nordisk announced headline results from the Phase 3 ZEUS cardiovascular outcomes trial evaluating...